226 related articles for article (PubMed ID: 22049515)
1. Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia.
Chen J; Petrus M; Bamford R; Shih JH; Morris JC; Janik JE; Waldmann TA
Blood; 2012 Jan; 119(1):137-43. PubMed ID: 22049515
[TBL] [Abstract][Full Text] [Related]
2. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
[TBL] [Abstract][Full Text] [Related]
3. Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα.
Sato N; Sabzevari H; Fu S; Ju W; Petrus MN; Bamford RN; Waldmann TA; Tagaya Y
Blood; 2011 Apr; 117(15):4032-40. PubMed ID: 21304101
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 and soluble interleukin-15 receptor α in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution.
Dozio E; Malavazos AE; Vianello E; Briganti S; Dogliotti G; Bandera F; Giacomazzi F; Castelvecchio S; Menicanti L; Sigrüener A; Schmitz G; Corsi Romanelli MM
PLoS One; 2014; 9(3):e90960. PubMed ID: 24603895
[TBL] [Abstract][Full Text] [Related]
5. The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.
Wu Z; Xue HH; Bernard J; Zeng R; Issakov D; Bollenbacher-Reilley J; Belyakov IM; Oh S; Berzofsky JA; Leonard WJ
Blood; 2008 Dec; 112(12):4411-9. PubMed ID: 18796634
[TBL] [Abstract][Full Text] [Related]
6. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
7. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.
Perrier C; Arijs I; Staelens D; Breynaert C; Cleynen I; Covens K; Ferrante M; Van Assche G; Vermeire S; de Hertogh G; Schuit F; Rutgeerts P; Ceuppens JL
Immunology; 2013 Jan; 138(1):47-56. PubMed ID: 23039249
[TBL] [Abstract][Full Text] [Related]
9. IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.
Shi Y; Dincheva-Vogel L; Ayemoba CE; Fung JP; Bergamaschi C; Pavlakis GN; Farzaneh F; Gaensler KML
Blood Adv; 2018 Nov; 2(22):3177-3192. PubMed ID: 30482760
[TBL] [Abstract][Full Text] [Related]
10. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.
Yang J; Liu X; Nyland SB; Zhang R; Ryland LK; Broeg K; Baab KT; Jarbadan NR; Irby R; Loughran TP
Blood; 2010 Jan; 115(1):51-60. PubMed ID: 19880494
[TBL] [Abstract][Full Text] [Related]
12. MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Rα complex.
Stoklasek TA; Colpitts SL; Smilowitz HM; Lefrançois L
J Immunol; 2010 Dec; 185(11):6857-65. PubMed ID: 21041729
[TBL] [Abstract][Full Text] [Related]
13. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
14. Selective reduction of post-selection CD8 thymocyte proliferation in IL-15Rα deficient mice.
Chow KP; Qiu JT; Lee JM; Hsu SL; Yang SC; Wu NN; Huang W; Wu TS
PLoS One; 2012; 7(3):e33152. PubMed ID: 22448237
[TBL] [Abstract][Full Text] [Related]
15. [Large granular lymphocytic leukemia CD3
Cupaiolo R; Cherifi S; Lelubre C; Govaerts D; Delefortrie Q; Corazza F; Chevalier C
Ann Biol Clin (Paris); 2018 Aug; 76(4):429-434. PubMed ID: 30078779
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia.
Wlodarski MW; Nearman Z; Jankowska A; Babel N; Powers J; Leahy P; Volk HD; Maciejewski JP
J Leukoc Biol; 2008 Mar; 83(3):589-601. PubMed ID: 18086899
[TBL] [Abstract][Full Text] [Related]
17. Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor alpha expression.
Quinn LS; Anderson BG; Strait-Bodey L; Wolden-Hanson T
Exp Gerontol; 2010 Feb; 45(2):106-12. PubMed ID: 19854259
[TBL] [Abstract][Full Text] [Related]
18. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
[TBL] [Abstract][Full Text] [Related]
19. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
[TBL] [Abstract][Full Text] [Related]
20. Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.
Chertova E; Bergamaschi C; Chertov O; Sowder R; Bear J; Roser JD; Beach RK; Lifson JD; Felber BK; Pavlakis GN
J Biol Chem; 2013 Jun; 288(25):18093-103. PubMed ID: 23649624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
